© 2005 by BMJ Publishing Group & British Cardiac Society
JournalScan
| The first 150 words of the full text of this article appear below. |
ISCHAEMIC HEART DISEASE

Although good at reducing restenosis, drug eluting stents (DES) have not yet been shown to reduce mortality. There is a known risk to performing non-cardiac surgery soon after bare metal stenting, presumably from stent thrombosis when endothelialisation has not occurred. However, operations done after six weeks appear to be safe even when antiplatelet agents are stopped. The same may not be true for DES. Four case reports are presented with clopidogrel having been stopped safely six months after DES. However, with the aspirin being stopped > 30 days after the first procedure in preparation for non-cardiac surgery, 45 days later, in-stent thrombosis of the DES occurred. The cause is not clear, but presumably poor endothelialisation may play a part. Plankeep the aspirin going if at all possible.
McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
